Sepsis News and Research

Latest Sepsis News and Research

Physician's choice of words play important role in determining critical end-of-life decisions

A physician's choice of words when talking with family members about whether or not to try cardiopulmonary resuscitation if a critically ill patient's heart stops may influence the decision, according to a study by University of Pittsburgh researchers in the June edition of Critical Care Medicine and now available online.

10 May 2013

PCNL procedure to remove kidney stones in women has risen in recent years, study reveals

While the number of people - especially women - who have a minimally invasive procedure to remove kidney stones has risen in recent years, so has the rate of complications related to the surgery, according to a published study by Henry Ford Hospital in Detroit.

8 May 2013

U-M launches new center for treating patients with critical conditions

America's emergency, trauma and intensive care teams provide some of the world's most advanced care, bringing patients back from the brink of death on a regular basis.

5 May 2013

Scientists pursue new therapies as H7N9 flu spreads in China

An experimental drug has shown promise in treating influenza, preventing lung injury and death from the virus in preclinical studies, according to University of Maryland School of Medicine researchers publishing in the journal Nature on May 1.

2 May 2013

Pancreatitis and diabetes drugs: an interview with Dr Sonal Singh, Johns Hopkins University School of Medicine

Acute pancreatitis is an inflammation of the pancreas which leads to leakage of pancreatic enzymes. Apart from certain drugs such as GLP-1 based therapies, the most common causes of pancreatitis are Gallstones and Alcohol use.

30 Apr 2013

Personalized PSA testing using genetic variants reduces unnecessary prostate biopsies

With the help of genetics, prostate specific antigen screenings may become more accurate and reduce the number of unnecessary prostate biopsies, according to a new study from Northwestern Medicine.

25 Apr 2013

ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

ViroPharma Incorporated, an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections.

23 Apr 2013

Researcher discovers additional mechanical properties of articular cartilage result in osteoarthritis

A researcher at The Feinstein Institute for Medical Research has discovered additional mechanical properties of articular cartilage, a protective cartilage on the ends of bones that wears down over time, resulting in the development of osteoarthritis.

20 Apr 2013

Average annual incidence of sepsis varies depending on method used

Though the toll of sepsis is known to be enormous - it is estimated to cost the U.S. health care system $24.3 billion each year, and is the nation's third-leading killer, behind heart disease and cancer - the true magnitude of incidence of and death from the illness remains unknown.

16 Apr 2013

Correcting prostate specific antigen levels for genetic variants can have significant consequences

Genetic variants have been identified which can increase serum prostate specific antigen concentrations and prostate cancer risk. A new study published in The Journal of Urology reports that correcting PSA levels for these genetic variants can have significant consequences, including avoiding unnecessary biopsies for some men and eliminating false complacency for others.

16 Apr 2013

Research findings could lead to new targets for treating inflammatory disorders

Researchers at UC Davis have shown how the innate immune system distinguishes between dangerous pathogens and friendly microbes. Like burglars entering a house, hostile bacteria give themselves away by breaking into cells. However, sensing proteins instantly detect the invasion, triggering an alarm that mobilizes the innate immune response.

2 Apr 2013

Research findings could improve treatments for pneumonia, other inflammatory conditions

Scientists at the University of Pittsburgh School of Medicine have discovered a new biological pathway of innate immunity that ramps up inflammation and then identified agents that can block it, leading to increased survival and improved lung function in animal models of pneumonia.

1 Apr 2013

Research roundup: Despite some cuts, hospitals will benefit from Medicaid expansion; Medicare's rising costs propel efforts to revamp the program

The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.

30 Mar 2013

GE Healthcare seeks approval to supply Optison to EU market from Oslo manufacturing facility

GE Healthcare today announced that it has submitted an application to amend its European Marketing Authorisation that will allow the company to manufacture Optison 0.19 mg/ml dispersion for injection within its own facility.

30 Mar 2013

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

Inflammation can be thought of as taking two major forms: acute or chronic. Acute inflammation, which can be painful, usually arises quickly and resolves quickly. It accompanies bacterial infections, traumatic injury and is useful to fight infections and promote healing.

28 Mar 2013

FDA clears Soligenix's IND application for SGX942 for treatment of oral mucositis

Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that the Food and Drug Administration has completed its review and cleared the Investigational New Drug application for SGX942 for the treatment of oral mucositis resulting from radiation and/or chemotherapy treatment in head and neck cancer patients.

27 Mar 2013

Minimally invasive procedure to remove kidney stones rise among women: Study

27 Mar 2013

Harvard scientists to further advance blood-cleansing technology for treating sepsis

The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that it was awarded a $9.25 million contract from the Defense Advanced Research Projects Agency to further advance a blood-cleansing technology developed at the Institute with prior DARPA support, and help accelerate its translation to humans as a new type of sepsis therapy.

26 Mar 2013

Eritoran drug does not reduce risk of death in patients with severe sepsis

Administration of the drug eritoran to patients with severe sepsis and septic shock failed to demonstrate a significant effect on reducing all-cause 28-day mortality or 1-year mortality, compared with placebo, according to a study in the March 20 issue of JAMA.

20 Mar 2013

Transfusion of older blood adversely affects patients undergoing cardiac surgery or critical care

Transfusion of donated blood more than three weeks old results in impaired blood vessel function, a new study of hospital patients shows.

11 Mar 2013

Sepsis News and Research

Latest Sepsis News and Research

Physician's choice of words play important role in determining critical end-of-life decisions

PCNL procedure to remove kidney stones in women has risen in recent years, study reveals

U-M launches new center for treating patients with critical conditions

Scientists pursue new therapies as H7N9 flu spreads in China

Pancreatitis and diabetes drugs: an interview with Dr Sonal Singh, Johns Hopkins University School of Medicine

Personalized PSA testing using genetic variants reduces unnecessary prostate biopsies

ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

Researcher discovers additional mechanical properties of articular cartilage result in osteoarthritis

Average annual incidence of sepsis varies depending on method used

Correcting prostate specific antigen levels for genetic variants can have significant consequences

Research findings could lead to new targets for treating inflammatory disorders

Research findings could improve treatments for pneumonia, other inflammatory conditions

Research roundup: Despite some cuts, hospitals will benefit from Medicaid expansion; Medicare's rising costs propel efforts to revamp the program

GE Healthcare seeks approval to supply Optison to EU market from Oslo manufacturing facility

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

FDA clears Soligenix's IND application for SGX942 for treatment of oral mucositis

Minimally invasive procedure to remove kidney stones rise among women: Study

Harvard scientists to further advance blood-cleansing technology for treating sepsis

Eritoran drug does not reduce risk of death in patients with severe sepsis

Transfusion of older blood adversely affects patients undergoing cardiac surgery or critical care

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Sepsis News and Research

Latest Sepsis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in